E4D-30303-67362
2 vaccinations
1 coded response
14 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 229 / VA
- Registered
- 2022-07-23
- Relationship
- Child or adolescent in my care
- Guardian
- 6BR-33289-90578
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-11
Dose 1 — Pfizer-BioNTech
-
2022-07-23
Registered in v-safe
- 2022-07-23
- 2022-07-25
- 2022-08-01
-
2022-08-08
Dose 2 — Pfizer-BioNTech
- 2022-08-10
- 2022-08-11
- 2022-08-12
- 2022-08-13
- 2022-08-14
- 2022-08-15
- 2022-08-22
- 2022-08-29
- 2022-09-05
- 2022-09-12
-
2023-02-06
Survey response — 6 months, dose 2, under 3MedDRA: Rhinorrhoea — Feeling: FairMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-11 | Pfizer-BioNTech | No |
| 2 | 2022-08-08 | Pfizer-BioNTech | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release